We suggest that the extraction protocol followed in this study, extracting extracellular vesicles from blood plasma followed by enrichment of neural vesicles using L1CAM, leads to a more relevant pool of miRNA that is directly associated with neurodegenerative processes, is repeatable, and might be specifically useful as biomarkers for ALS/MND. Here, L1CAM is linked to amyotrophic lateral sclerosis.